About M2S
M2S is a company based in Lebanon (United States) founded in 1997 was acquired by Medstreaming in March 2016. M2S has raised $1.63 million across 2 funding rounds from investors including Medstreaming, FreshTracks Capital and Altaris. The company has 84 employees as of December 31, 2021. M2S offers products and services including Data Services, Registries, and Platform Services. M2S operates in a competitive market with competitors including ClearDATA, Carta Healthcare, Kyruus Health, SD Biosensor and Clearsense, among others.
- Headquarter Lebanon, United States
- Employees 84 as on 31 Dec, 2021
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.63 M (USD)
in 2 rounds
-
Latest Funding Round
$1.63 M (USD), Series A
Dec 20, 2012
-
Investors
Medstreaming
& 2 more
-
Employee Count
84
as on Dec 31, 2021
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of M2S
M2S offers a comprehensive portfolio of products and services, including Data Services, Registries, and Platform Services.
Captures clinical data for device manufacturers to improve outcomes
Supports medical societies in developing and maintaining registries
Provides tools for patient-reported outcomes and analytics
Funding Insights of M2S
M2S has successfully raised a total of $1.63M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.63 million completed in December 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in M2S
M2S has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Medstreaming, FreshTracks Capital and Altaris.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital funding is provided by FreshTracks Capital.
|
Locked | Locked | Locked | |
|
PE firm invests in the US
|
Locked | Locked | Locked | |
|
Workflow software solutions for cardiovascular and radiology are offered.
|
Locked | Locked | Locked |
Investor details for M2S
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by M2S
Investment portfolio details for M2S
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - M2S
Detailed financials for M2S
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
M2s Comparisons
Peer comparison for M2S
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of M2S
M2S operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ClearDATA, Carta Healthcare, Kyruus Health, SD Biosensor and Clearsense, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based clinical data management platform for healthcare providers
|
|
| Locked | Locked | Locked |
AI-driven clinical data management tools are offered to healthcare providers.
|
|
| Locked | Locked | Locked |
Software solutions for clinical decision making are provided.
|
|
| Locked | Locked | Locked |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| Locked | Locked | Locked |
Healthcare analytics platforms and applications are developed for clinicians.
|
|
| Locked | Locked | Locked |
Verana Health is focused on real-world data analytics in healthcare.
|
Detailed competitors of M2S
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on M2s
Complete news archive for M2S
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about M2S
M2S was founded in 1997 and raised its 1st funding round 6 years after it was founded.
M2S is headquartered in Lebanon, United States.
Wael Elseaidy is the current CEO of M2S.
M2S is a funded company, having raised a total of $1.63M across 2 funding rounds to date.
As of Dec 31, 2021, the latest employee count at M2S is 84.
M2S (formerly Medical Metrix Solutions) provides technology solutions and services to manage clinical information and enhance the quality of patient care. The company offers Preview, a tool that provides an interactive 3D model and measurements for endovascular case planning to handle the AAA, TAA, TEVAR BEVAR, and TAVR cases, and PATHWAYS, a web-based SaaS system data collection, reporting, and analysis platform. It also provides solutions in the areas of clinical registries, pre-market, clinical trials, and post-approval projects, data mining and custom measurements, and cardiovascular imaging.
M2S's top competitors include Carta Healthcare, Truveta and ClearDATA.
M2S offers Data Services, Registries, and Platform Services.
M2S has 3 investors. Key investors include Medstreaming, FreshTracks Capital, and Altaris.